Developer docs
API playgroundTry for free, no card

Search company profiles

IntegReview

Full company profile

uuid0009j4m

Namestring
IntegReview
Legal namestring
Advarra
Websiteurl
integreview.com
Company typeenum
Private
Founded yearint
1977
Descriptiontext

IntegReview operates today as Advarra, the largest central Institutional Review Board (IRB) in the independent segment, providing ethical oversight and protocol review for the majority of industry-sponsored clinical trials in the United States and Canada. The company was formed in 1977 through the unification of several leading independent IRBs — IntegReview among them — combining their governance models and reviewer expertise into a single platform. Advarra supports more than 72,000 research sites and reviews 36,000+ U.S. site submissions and 1,600+ Canadian submissions annually, with deep specialization in oncology (2x more oncology protocols reviewed than any other independent IRB, 100% of oncology indications, 7x more oncology-representative meetings per week, and 400+ oncology experts on roster).

The product surface centers on the proprietary CIRBI platform — a secure, single-source-of-truth system for IRB submissions, required actions, study status, and board decisions — integrated with sponsor-side Study Collaboration tooling, the Braid Data and AI Engine (powering the 2024 Study Design Solution), and a portfolio of site-side systems (OnCore and Clinical Conductor CTMS, eReg, eSource). Adjacent review services include Institutional Biosafety Committee (IBC), Data Monitoring Committee (DMC), and GxP compliance offerings. Preferred-provider relationships cover all NCI Designated Cancer Centers plus SCRI and START.

Revenue is generated through quote-based, subscription-style contracts for IRB and ancillary review services, sold primarily via an enterprise direct-sales motion (dedicated coordinators serve as single points of contact) supplemented by the CIRBI portal for ongoing submission management. The customer base spans emerging biotechs, all top-20 pharmaceutical companies, leading CROs, and 72,000+ research sites, with 87% of submissions coming from returning customers — evidence of a durable, recurring revenue model anchored in regulatory necessity rather than discretionary spend.

Short descriptiontext

IntegReview, operating as Advarra, is the largest central Institutional Review Board providing ethical oversight for industry-sponsored clinical trials, serving pharma, biotechs, CROs, and 72,000+ research sites across the U.S. and Canada via its proprietary CIRBI platform and Braid AI engine.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
institutional review board, clinical trial ethics, central IRB services, biosafety committee review, data monitoring committee
Industry3 codes
PRIMARYHLAJACAG
Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYEDAOAJAO
Clinical Research Support (CRC/CTA)
Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training
NAICS code1 code
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Ethics Review Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1IRB Review Services
TypeSubscription Recurring
Description

Advarra provides ethical oversight and review services for clinical trials. They are described as the largest central IRB providing independent, rigorous oversight for the majority of industry-sponsored trials.

advarra.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Pricing details1 tier
1Custom enterprise pricing based on organization needs and submission volume
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed

advarra.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1CIRBI
Description

Advarra's secure, proprietary platform that supports the gold-standard IRB process. A single source of truth for submissions, required actions, study status, and board decisions.

advarra.com
Core offering1 text field

IntegReview provides independent Institutional Review Board (IRB) services for industry-sponsored clinical trials, delivering ethical oversight, protocol review, and ongoing study review across the United States and Canada. The offering is delivered through the CIRBI proprietary platform and is supported by adjacent review services including Institutional Biosafety Committee (IBC), Data Monitoring Committee (DMC), and GxP compliance intelligence, primarily to pharmaceutical and biotech sponsors, CROs, and more than 72,000 research sites.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • First decisions on protocol submissions average five days after all required materials are received
+3 more records
Product overview1 text field

Advarra offers a unified IRB platform combined with clinical trial technology solutions. The core offering is CIRBI, a proprietary IRB platform that serves as the single source of truth for submissions, required actions, study status, and board decisions. This integrates with the Study Collaboration platform for sponsors and CROs, and CTMS solutions (OnCore, Clinical Conductor) for sites. The Braid Data and AI Engine powers study design and operational automation. Additional offerings include IBC Services, DMC Services, GxP Compliance Intelligence, eReg, and eSource for regulatory and clinical documentation management.

Product and service10 records
1IRB Services
CategoryCore IRB Review Service
Description

Independent, rigorous Institutional Review Board oversight with speed and transparency, providing ethical oversight for industry-sponsored trials across more than 72,000 research sites serving emerging biotechs through top-20 pharma and leading CROs.

2IBC Services
CategoryBiosafety Review Service
Description

Institutional Biosafety Committee services reviewing the biosafety aspects of research, particularly for advanced therapeutic modalities such as cell and gene therapy.

3DMC Services
CategoryData Monitoring Service
Description

Data Monitoring Committee services providing oversight of safety data in clinical trials.

4GxP Compliance Intelligence
CategoryCompliance Review Service
Description

GxP compliance intelligence services providing reviews and audits to support regulatory compliance in clinical research.

5OnCore CTMS
CategorySite Clinical Trial Management System
Description

Clinical Trial Management System solution used by research sites and institutions to manage clinical trial operations.

6Clinical Conductor CTMS
CategorySite Clinical Trial Management System
Description

Clinical Trial Management System solution used by research sites and institutions to manage clinical trial operations.

7eReg
CategoryElectronic Regulatory Management
Description

Electronic regulatory management solution for sites and institutions, with direct integration to IRB submissions to streamline documentation.

8eSource
CategoryElectronic Source Documentation
Description

Electronic source documentation solution for sites and institutions to capture clinical trial source data electronically.

9Study Collaboration
CategorySponsor/CRO Collaboration Platform
Description

Platform for sponsors and CROs to collaborate on study design, site identification and feasibility, study startup, site collaboration and training, and enrollment planning and tracking.

10Braid Data and AI Engine
CategoryAI Study Design Engine
Description

Data and AI engine powering study design and other operational intelligence and automation solutions for clinical trials.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1SCRI (Sarah Cannon Research Institute)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Advarra is the preferred provider for IRB and IBC services for SCRI's late-stage trials. This partnership leverages SCRI's oncology research expertise with Advarra's regulatory oversight capabilities.

advarra.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Advarra and START united to deliver unmatched speed, quality, and predictability for early-phase oncology trials. Advarra serves as preferred IRB and IBC partner for START's early-phase oncology research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Advarra supports all NCI Designated Cancer Centers with IRB services, providing ethical oversight for oncology research conducted across these prestigious research institutions.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IntegReview

Clinical Research Ethics Review Servicesintegreview.com

IntegReview, operating as Advarra, is the largest central Institutional Review Board providing ethical oversight for industry-sponsored clinical trials, serving pharma, biotechs, CROs, and 72,000+ research sites across the U.S. and Canada via its proprietary CIRBI platform and Braid AI engine.

What IntegReview does

IntegReview operates today as Advarra, the largest central Institutional Review Board (IRB) in the independent segment, providing ethical oversight and protocol review for the majority of industry-sponsored clinical trials in the United States and Canada. The company was formed in 1977 through the unification of several leading independent IRBs — IntegReview among them — combining their governance models and reviewer expertise into a single platform. Advarra supports more than 72,000 research sites and reviews 36,000+ U.S. site submissions and 1,600+ Canadian submissions annually, with deep specialization in oncology (2x more oncology protocols reviewed than any other independent IRB, 100% of oncology indications, 7x more oncology-representative meetings per week, and 400+ oncology experts on roster).

The product surface centers on the proprietary CIRBI platform — a secure, single-source-of-truth system for IRB submissions, required actions, study status, and board decisions — integrated with sponsor-side Study Collaboration tooling, the Braid Data and AI Engine (powering the 2024 Study Design Solution), and a portfolio of site-side systems (OnCore and Clinical Conductor CTMS, eReg, eSource). Adjacent review services include Institutional Biosafety Committee (IBC), Data Monitoring Committee (DMC), and GxP compliance offerings. Preferred-provider relationships cover all NCI Designated Cancer Centers plus SCRI and START.

Revenue is generated through quote-based, subscription-style contracts for IRB and ancillary review services, sold primarily via an enterprise direct-sales motion (dedicated coordinators serve as single points of contact) supplemented by the CIRBI portal for ongoing submission management. The customer base spans emerging biotechs, all top-20 pharmaceutical companies, leading CROs, and 72,000+ research sites, with 87% of submissions coming from returning customers — evidence of a durable, recurring revenue model anchored in regulatory necessity rather than discretionary spend.

IntegReview firmographics

Firmographics
Name
IntegReview
Legal name
Advarra
Website
https://integreview.com
Company type
Private
Founded year
1977
Operating status
Operating
Headcount range
1–10 employees
Short description
IntegReview, operating as Advarra, is the largest central Institutional Review Board providing ethical oversight for industry-sponsored clinical trials, serving pharma, biotechs, CROs, and 72,000+ research sites across the U.S. and Canada via its proprietary CIRBI platform and Braid AI engine.
Ownership category
akta.pro rank

IntegReview industry classification

Industry
Product category
Clinical Research Ethics Review Services
NAICS
Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAJACAG
Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYEDAOAJAO
Clinical Research Support (CRC/CTA)
Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training

Keywords

  • Institutional review board
  • Clinical trial ethics
  • Central IRB services
  • Biosafety committee review
  • Data monitoring committee

Where IntegReview is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Markets served

IntegReview business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. IRB Review Services: Advarra provides ethical oversight and review services for clinical trials. They are described as the largest central IRB providing independent, rigorous oversight for the majority of industry-sponsored trials.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualCustom enterprise pricing based on organization needs and submission volume

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

IntegReview product offering

Product offering

Core offering

IntegReview provides independent Institutional Review Board (IRB) services for industry-sponsored clinical trials, delivering ethical oversight, protocol review, and ongoing study review across the United States and Canada. The offering is delivered through the CIRBI proprietary platform and is supported by adjacent review services including Institutional Biosafety Committee (IBC), Data Monitoring Committee (DMC), and GxP compliance intelligence, primarily to pharmaceutical and biotech sponsors, CROs, and more than 72,000 research sites.

Product overview

Advarra offers a unified IRB platform combined with clinical trial technology solutions. The core offering is CIRBI, a proprietary IRB platform that serves as the single source of truth for submissions, required actions, study status, and board decisions. This integrates with the Study Collaboration platform for sponsors and CROs, and CTMS solutions (OnCore, Clinical Conductor) for sites. The Braid Data and AI Engine powers study design and operational automation. Additional offerings include IBC Services, DMC Services, GxP Compliance Intelligence, eReg, and eSource for regulatory and clinical documentation management.

Differentiator

Problem solved

Functional benefit

Brands

  • CIRBI: Advarra's secure, proprietary platform that supports the gold-standard IRB process. A single source of truth for submissions, required actions, study status, and board decisions.

Products and services

  • IRB Services Independent, rigorous Institutional Review Board oversight with speed and transparency, providing ethical oversight for industry-sponsored trials across more than 72,000 research sites serving emerging biotechs through top-20 pharma and leading CROs.
  • IBC Services Institutional Biosafety Committee services reviewing the biosafety aspects of research, particularly for advanced therapeutic modalities such as cell and gene therapy.
  • DMC Services Data Monitoring Committee services providing oversight of safety data in clinical trials.
  • GxP Compliance Intelligence GxP compliance intelligence services providing reviews and audits to support regulatory compliance in clinical research.
  • OnCore CTMS Clinical Trial Management System solution used by research sites and institutions to manage clinical trial operations.
  • Clinical Conductor CTMS Clinical Trial Management System solution used by research sites and institutions to manage clinical trial operations.
  • eReg Electronic regulatory management solution for sites and institutions, with direct integration to IRB submissions to streamline documentation.
  • eSource Electronic source documentation solution for sites and institutions to capture clinical trial source data electronically.
  • Study Collaboration Platform for sponsors and CROs to collaborate on study design, site identification and feasibility, study startup, site collaboration and training, and enrollment planning and tracking.
  • Braid Data and AI Engine Data and AI engine powering study design and other operational intelligence and automation solutions for clinical trials.

Quantifiable outcome

  • First decisions on protocol submissions average five days after all required materials are received
  • +3 more outcomes

Companies that use IntegReview

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles3 records

IntegReview technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature2 records

IntegReview partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • SCRI (Sarah Cannon Research Institute)coreStrategic or Co-development PartnerAdvarra is the preferred provider for IRB and IBC services for SCRI's late-stage trials. This partnership leverages SCRI's oncology research expertise with Advarra's regulatory oversight capabilities.
  • START (South Texas Accelerated Research Therapeutics)coreStrategic or Co-development PartnerAdvarra and START united to deliver unmatched speed, quality, and predictability for early-phase oncology trials. Advarra serves as preferred IRB and IBC partner for START's early-phase oncology research.
  • NCI Designated Cancer CenterscoreStrategic or Co-development PartnerAdvarra supports all NCI Designated Cancer Centers with IRB services, providing ethical oversight for oncology research conducted across these prestigious research institutions.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

IntegReview competitors and assessment

Company assessment

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

IntegReview social profiles

Digital presence

IntegReview financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IntegReview leadership team

Management profile

Number of profiles

Profiles1 record

IntegReview funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IntegReview M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IntegReview

What does IntegReview do?

IntegReview provides independent Institutional Review Board (IRB) services for industry-sponsored clinical trials, delivering ethical oversight, protocol review, and ongoing study review across the United States and Canada. The offering is delivered through the CIRBI proprietary platform and is supported by adjacent review services including Institutional Biosafety Committee (IBC), Data Monitoring Committee (DMC), and GxP compliance intelligence, primarily to pharmaceutical and biotech sponsors, CROs, and more than 72,000 research sites.

Is IntegReview a public or private company?

IntegReview is a private company. It is classified as unknown and is currently operating.

When was IntegReview founded?

IntegReview was founded in 1977. It employs 1 to 10 people.

Where is IntegReview based?

IntegReview is headquartered in Austin, United States, in the North America region.

How does IntegReview make money?

One revenue line is on record: IRB Review Services.

Does IntegReview have an API?

No public API is recorded for IntegReview.

What industry is IntegReview in?

IntegReview's product category is Clinical Research Ethics Review Services. Its primary akta.pro industry code is HLAJACAG, Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight), with a secondary code of HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 54169 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals